{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:27:02Z","timestamp":1793820422603,"version":"4.6.1"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.forsciint.2024.112240","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T17:25:51Z","timestamp":1728667551000},"page":"112240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Unravelling the threat of contamination in elite sports: Exploring diverse sources impacting adverse analytical findings and the risk of inadvertent exposure to prohibited substances"],"prefix":"10.1016","volume":"365","author":[{"given":"Ana Belen Moraleda","family":"Merlo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Lobigs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Piper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Champod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.forsciint.2024.112240_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.15171\/apb.2018.062","article-title":"Doping in sports, a never-ending story\u00a0?","volume":"8","author":"Vlad","year":"2018","journal-title":"Adv. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.forsciint.2024.112240_bib2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/anatox\/35.9.608","article-title":"The list of prohibited substances and methods in sport: structure and review process by the world anti-doping agency","volume":"35","author":"Mazzoni","year":"2011","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2024.112240_bib3","unstructured":"1967: Creation of the IOC Medical Commission. [Online]. Available: \u3008https:\/\/olympics.com\/ioc\/1967-creation-of-the-ioc-medical-commission\u3009."},{"issue":"2","key":"10.1016\/j.forsciint.2024.112240_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-0838.2011.01370.x","article-title":"The development of doping use in high-level cycling: from team-organized doping to advances in the fight against doping","volume":"23","author":"Lentillon-Kaestner","year":"2013","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"10.1016\/j.forsciint.2024.112240_bib5","unstructured":"World Anti-Doping Agency, World Anti-Doping Code. [Online]. Available: \u3008https:\/\/www.wada-ama.org\/en\/resources\/world-anti-doping-code-and-international-standards\/world-anti-doping-code#resource-download\u3009."},{"key":"10.1016\/j.forsciint.2024.112240_bib6","unstructured":"WADA), World Anti-Doping Code International Standard Prohibited List. 2024. Accessed: Jan. 24, 2024. [Online]. Available: \u3008https:\/\/www.wada-ama.org\/en\/resources\/world-anti-doping-code-and-international-standards\/prohibited-list\u3009."},{"issue":"3","key":"10.1016\/j.forsciint.2024.112240_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/17511321.2017.1351483","article-title":"Ideology, Doping and the Spirit of Sport","volume":"12","author":"Geeraets","year":"2018","journal-title":"Sport Ethics Philos."},{"key":"10.1016\/j.forsciint.2024.112240_bib8","unstructured":"Goldman B., Bush P.J., Klatz R., Death in the Locker room, 32. London, 1984."},{"issue":"1","key":"10.1016\/j.forsciint.2024.112240_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40279-017-0765-4","article-title":"Doping in two elite athletics competitions assessed by randomized-response surveys","volume":"48","author":"Ulrich","year":"2018","journal-title":"Sports Med"},{"issue":"4","key":"10.1016\/j.forsciint.2024.112240_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/10826084.2010.502553","article-title":"Motives for illicit use of doping substances among athletes calling a national antidoping phone-help service: an exploratory study","volume":"46","author":"Bilard","year":"2011","journal-title":"Subst. Use Misuse"},{"issue":"10","key":"10.1016\/j.forsciint.2024.112240_bib11","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.3390\/ijerph18105411","article-title":"The motivational underpinnings of intentions to use doping in sport: a sample of young non-professional athletes","volume":"18","author":"Chirico","year":"2021","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"10.1016\/j.forsciint.2024.112240_bib12","unstructured":"Wada Anti-doping Agency, Anti-doping Testing Figures Reports. [Online]. Available: \u3008https:\/\/www.wada-ama.org\/en\/data-research\/anti-doping-statistics\u3009."},{"issue":"10","key":"10.1016\/j.forsciint.2024.112240_bib13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3390\/nu9101093","article-title":"Intended or unintended doping? A review of the presence of doping substances in dietary supplements used in sports","volume":"9","author":"Mart\u00ednez-Sanz","year":"2017","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.forsciint.2024.112240_bib14","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.fshw.2023.03.001","article-title":"Foodborne doping and supervision in sports","volume":"12","author":"Chen","year":"2023","journal-title":"Food Sci. Hum. Wellness"},{"issue":"5","key":"10.1016\/j.forsciint.2024.112240_bib15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/dta.1471","article-title":"Adverse analytical findings with clenbuterol among U-17 soccer players attributed to food contamination issues","volume":"5","author":"Thevis","year":"2013","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2024.112240_bib16","unstructured":"European Chemical Database. [Online]. Available: \u3008https:\/\/echa.europa.eu\/substance-information\/-\/substanceinfo\/100.048.499\u3009."},{"key":"10.1016\/j.forsciint.2024.112240_bib17","unstructured":"Estadistica de comercio exterior de bienes de Espana y la UE. [Online]. Available: \u3008https:\/\/datacomex.comercio.es\/Data\u3009."},{"key":"10.1016\/j.forsciint.2024.112240_bib18","article-title":"Dopaje con clenbuterol: \u00bfes posible la contaminaci\u00f3n con carne en el \u201cCaso del ciclista Alberto Contador\u201d?","volume":"11","author":"Santos","year":"2013","journal-title":"Cult. F. \u00c1RMACOS"},{"issue":"3","key":"10.1016\/j.forsciint.2024.112240_bib20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/bmc.928","article-title":"Clenbuterol marketed as dietary supplement","volume":"22","author":"Parr","year":"2008","journal-title":"Biomed. Chromatogr."},{"issue":"6","key":"10.1016\/j.forsciint.2024.112240_bib21","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/dta.1330","article-title":"Clenbuterol - regional food contamination a possible source for inadvertent doping in sports","volume":"4","author":"Guddat","year":"2012","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2024.112240_bib22","unstructured":"WADA), Stakeholder Notice regarding potential meat contamination cases. 2021. Accessed: Jan. 24, 2024. [Online]. Available: \u3008https:\/\/www.wada-ama.org\/en\/resources\/stakeholder-notice-regarding-potential-meat-contamination-cases\u3009."},{"issue":"19","key":"10.1016\/j.forsciint.2024.112240_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9357","article-title":"Determination and enantioselective separation of zilpaterol in human urine after mimicking consumption of contaminated meat using high-performance liquid chromatography with tandem mass spectrometry techniques","volume":"36","author":"Euler","year":"2022","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"13\u201314","key":"10.1016\/j.forsciint.2024.112240_bib24","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.steroids.2006.09.009","article-title":"Criteria to distinguish between natural situations and illegal use of boldenone, boldenone esters and boldione in cattle","volume":"71","author":"Le Bizec","year":"2006","journal-title":"Steroids"},{"key":"10.1016\/j.forsciint.2024.112240_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.envint.2012.10.002","article-title":"Transfer of eight phthalates through the milk chain \u2014 A case study","volume":"51","author":"Fierens","year":"2013","journal-title":"Environ. Int."},{"key":"10.1016\/j.forsciint.2024.112240_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.theriogenology.2017.08.025","article-title":"Aromatase inhibitors: A new approach for controlling ovarian function in cattle","volume":"112","author":"Yapura","year":"2018","journal-title":"Theriogenology"},{"key":"10.1016\/j.forsciint.2024.112240_bib27","series-title":"Use of an aromatase inhibitor for ovarian synchronization in cattle","author":"Zwiefelhofer","year":"2020"},{"issue":"6","key":"10.1016\/j.forsciint.2024.112240_bib28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/dta.2555","article-title":"Hair analysis to discriminate voluntary doping vs inadvertent ingestion of the aromatase inhibitor letrozole","volume":"11","author":"Favretto","year":"2019","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2024.112240_bib29","unstructured":"case ADT02.2023 UCIv. Mr. Toon Aerts. 2023."},{"issue":"11\u201312","key":"10.1016\/j.forsciint.2024.112240_bib30","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/dta.352","article-title":"Zeranol: doping offence or mycotoxin? A case-related study","volume":"3","author":"Thevis","year":"2011","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2024.112240_bib31","unstructured":"World Anti-Doping Agency, WADA Technical Letter \u2013 TL04 Analysis and reporting of zeranol. 2021."},{"issue":"1","key":"10.1016\/j.forsciint.2024.112240_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jat\/27.1.53","article-title":"Urinary Concentrations of Morphine and Codeine After Consumption of Poppy Seeds","volume":"27","author":"Thevis","year":"2003","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.forsciint.2024.112240_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/jat\/bkaa190","article-title":"Analysis of Cocaine and Its Metabolites in Urine after Consumption of Coca Tea by Five Subjects and Subsequent Hair Testing","volume":"46","author":"Feisthauer","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2024.112240_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2022.339661","article-title":"Assessing human urinary clomiphene metabolites after consumption of eggs from clomiphene-treated laying hens using chromatographic-mass spectrometric approaches","volume":"1202","author":"Euler","year":"2022","journal-title":"Anal. Chim. Acta"},{"issue":"11","key":"10.1016\/j.forsciint.2024.112240_bib35","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1080\/19440049.2021.1949497","article-title":"Depletion of clomiphene residues in eggs and muscle after oral administration to laying hens","volume":"38","author":"Seyerlein","year":"2021","journal-title":"Food Addit. Contam. Part A"},{"key":"10.1016\/j.forsciint.2024.112240_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2019.121441","article-title":"Micropollutants in Lake Como water in the context of circular economy: A snapshot of water cycle contamination in a changing pollution scenario","volume":"384","author":"Castiglioni","year":"2020","journal-title":"J. Hazard. Mater."},{"issue":"9","key":"10.1016\/j.forsciint.2024.112240_bib37","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.chemosphere.2013.07.057","article-title":"Pharmaceuticals and personal care products found in the Great Lakes above concentrations of environmental concern","volume":"93","author":"Blair","year":"2013","journal-title":"Chemosphere"},{"key":"10.1016\/j.forsciint.2024.112240_bib38","unstructured":"ASADA v. Tate Smith. 2015."},{"key":"10.1016\/j.forsciint.2024.112240_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.fsigen.2017.02.008","article-title":"Helping to distinguish primary from secondary transfer events for trace DNA","volume":"28","author":"Taylor","year":"2017","journal-title":"Forensic Sci. Int. Genet."},{"issue":"11\u201312","key":"10.1016\/j.forsciint.2024.112240_bib42","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/dta.3187","article-title":"Sports drug testing and the athletes\u2019 exposome","volume":"13","author":"Thevis","year":"2021","journal-title":"Drug Test. Anal."},{"issue":"1\u20132","key":"10.1016\/j.forsciint.2024.112240_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ansa.202100058","article-title":"Probing for the presence of semenogelin in human urine by immunological and chromatographic-mass spectrometric methods in the context of sports drug testing","volume":"3","author":"Breuer","year":"2022","journal-title":"Anal. Sci. Adv."},{"issue":"9","key":"10.1016\/j.forsciint.2024.112240_bib44","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/dta.3331","article-title":"Sexually transmitted doping: the impact of urine contamination of semen","volume":"14","author":"Handelsman","year":"2022","journal-title":"Drug Test. Anal."},{"issue":"2","key":"10.1016\/j.forsciint.2024.112240_bib45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1373\/clinchem.2003.022210","article-title":"Incidental clostebol contamination in athletes after sexual intercourse","volume":"50","author":"Pereira","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.forsciint.2024.112240_bib46","unstructured":"Arbitration CAS 2009\/A\/1926 International Tennis Federation (ITF) v. Richard Gasquet & CAS 2009\/A\/1930 World Anti-Doping Agency (WADA) v. ITF & Richard Gasquet, award of 17 December 2009. 2009. [Online]. Available: \u3008https:\/\/jurisprudence.tas-cas.org\/Shared%20Documents\/1926,%201930.pdf\u3009."},{"key":"10.1016\/j.forsciint.2024.112240_bib47","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.yrtph.2016.05.029","article-title":"The regulatory framework for preventing cross-contamination of pharmaceutical products: History and considerations for the future","volume":"79","author":"Sargent","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.forsciint.2024.112240_bib48","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.forsciint.2016.08.029","article-title":"Detection of the diuretic hydrochlorothiazide in a doping control urine sample as the result of a non-steroidal anti-inflammatory drug (NSAID) tablet contamination","volume":"267","author":"Helmlin","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2024.112240_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fspor.2021.692244","article-title":"Generic pharmaceuticals as a source of diuretic contamination in athletes subject to sport drug testing","volume":"3","author":"Eichner","year":"2021","journal-title":"Front. Sports Act. Living"},{"key":"10.1016\/j.forsciint.2024.112240_bib50","unstructured":"World Anti-Doping Agency, WADA Technical Letter \u2013 TL 24, Diuretics (contaminants of pharmaceutical products). 2021."},{"key":"10.1016\/j.forsciint.2024.112240_bib51","unstructured":"World Anti-Doping Agency (WADA), Stakeholder Notice regarding potential diuretic contamination cases. 2021. Accessed: Jan. 24, 2024. [Online]. Available: \u3008https:\/\/www.wada-ama.org\/en\/resources\/stakeholder-notice-regarding-potential-diuretic-contamination-cases\u3009."},{"issue":"4","key":"10.1016\/j.forsciint.2024.112240_bib52","doi-asserted-by":"crossref","DOI":"10.5812\/asjsm.28798","article-title":"Morphine\/Codeine Ratio, a Key in Investigating a Case of Doping","volume":"6","author":"Seif-Barghi","year":"2015","journal-title":"Asian J. Sports Med."},{"issue":"7","key":"10.1016\/j.forsciint.2024.112240_bib54","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jat\/bks058","article-title":"Excretion Profile of Hydrocodone, Hydromorphone and Norhydrocodone in Urine Following Single Dose Administration of Hydrocodone to Healthy Volunteers","volume":"36","author":"Valtier","year":"2012","journal-title":"J. Anal. Toxicol."},{"issue":"8","key":"10.1016\/j.forsciint.2024.112240_bib55","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/dta.1893","article-title":"Analytical detection of trimetazidine produced by metabolic conversion of lomerizine in doping control analysis","volume":"8","author":"Okano","year":"2016","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2024.112240_bib56","unstructured":"World Anti-Doping Agency, WADA Technical Letter \u2013 TL13, Trimetazidine. 2021."},{"key":"10.1016\/j.forsciint.2024.112240_bib57","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jpba.2015.07.017","article-title":"Formation of the diuretic chlorazanil from the antimalarial drug proguanil\u2014Implications for sports drug testing","volume":"115","author":"Thevis","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2024.112240_bib58","unstructured":"World Anti-Doping Agency, WADA Technical Letter \u2013 TL06, Possible metabolization of proguanil into chlorazanil. 2021."},{"issue":"11\u201312","key":"10.1016\/j.forsciint.2024.112240_bib59","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/dta.2051","article-title":"Risk of false positive results to SARM S-4 in case of therapeutic use of antineoplastic\/antiandrogen drug containing flutamide: a case study","volume":"8","author":"Perrenoud","year":"2016","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2024.112240_bib60","unstructured":"World Anti-Doping Agency, WADA Technical Letter \u2013 TL07, Andarine-Flutamide. 2021."},{"issue":"5","key":"10.1016\/j.forsciint.2024.112240_bib62","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/dta.2353","article-title":"Identification of oxymorphone as decomposition product of the permitted drug methylnaltrexone","volume":"10","author":"Sobolevsky","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"15","key":"10.1016\/j.forsciint.2024.112240_bib64","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/rcm.5100","article-title":"Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls","volume":"25","author":"Thevis","year":"2011","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.forsciint.2024.112240_bib65","unstructured":"World Anti-Doping Agency, WADA Technical Letter \u2013 TL12- Enobosarm (ostarine). 2021."},{"key":"10.1016\/j.forsciint.2024.112240_bib66","unstructured":"World Anti-Doping Agency, WADA Technical Letter \u2013 TL17- Detection of Tulobuterol in the presence of Bupropion. 2021."},{"issue":"8","key":"10.1016\/j.forsciint.2024.112240_bib67","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/foods9081012","article-title":"Dietary Supplement and Food Contaminations and Their Implications for Doping Controls","volume":"9","author":"Walpurgis","year":"2020","journal-title":"Foods"},{"issue":"7","key":"10.1016\/j.forsciint.2024.112240_bib68","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jms.1452","article-title":"Nutritional supplements cross-contaminated and faked with doping substances","volume":"43","author":"Geyer","year":"2008","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.forsciint.2024.112240_bib69","doi-asserted-by":"crossref","first-page":"1143187","DOI":"10.3389\/fnut.2023.1143187","article-title":"Trends in dietary supplement use among athletes selected for doping controls","volume":"10","author":"Lauritzen","year":"2023","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.forsciint.2024.112240_bib70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1941738117727736","article-title":"Prohibited Contaminants in Dietary Supplements","volume":"10","author":"Mathews","year":"2018","journal-title":"Sports Health Multidiscip. Approach"},{"issue":"2","key":"10.1016\/j.forsciint.2024.112240_bib71","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0838.2011.01374.x","article-title":"Gateway to doping? Supplement use in the context of preferred competitive situations, doping attitude, beliefs, and norms","volume":"23","author":"Backhouse","year":"2013","journal-title":"Scand. J. Med. Sci. Sports"},{"issue":"4","key":"10.1016\/j.forsciint.2024.112240_bib72","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/nu15040881","article-title":"Dietary Supplements: A Gateway to Doping?","volume":"15","author":"Mallick","year":"2023","journal-title":"Nutrients"},{"issue":"19","key":"10.1016\/j.forsciint.2024.112240_bib73","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.3390\/nu14194109","article-title":"Prevalence of Dietary Supplement Use among Athletes Worldwide: A Scoping Review","volume":"14","author":"Daher","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.forsciint.2024.112240_bib74","unstructured":"Mark Campbell Stuart, The essential and optimal analgesic and anti-inflammatory medicines for athletes at the Olympic Games, University College of London, 2023."},{"issue":"1","key":"10.1016\/j.forsciint.2024.112240_bib75","first-page":"2270722","article-title":"Investigation of the content of anabolic steroids in food supplements used in sports practice","volume":"16","author":"Petkova-Gueorguieva","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.forsciint.2024.112240_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/8387271","article-title":"Dietary Supplements as Source of Unintentional Doping","volume":"2022","author":"Kozhuharov","year":"2022","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.forsciint.2024.112240_bib77","unstructured":"USADA, Supplement Connect High Risk List. 2024. [Online]. Available: \u3008https:\/\/www.usada.org\/athletes\/substances\/supplement-connect\/high-risk-list\/\u3009."},{"key":"10.1016\/j.forsciint.2024.112240_bib78","unstructured":"The Cologne list. [Online]. Available: \u3008https:\/\/www.koelnerliste.com\/en\u3009."},{"issue":"3","key":"10.1016\/j.forsciint.2024.112240_bib79","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/plants11030354","article-title":"Higenamine in Plants as a Source of Unintentional Doping","volume":"11","author":"Rangelov Kozhuharov","year":"2022","journal-title":"Plants"},{"issue":"11\u201312","key":"10.1016\/j.forsciint.2024.112240_bib80","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/dta.3558","article-title":"Investigations into Annona fruit consumption as a potential source of dietary higenamine intake in the context of sports drug testing","volume":"15","author":"Rubio","year":"2023","journal-title":"Drug Test. Anal."},{"issue":"3","key":"10.1016\/j.forsciint.2024.112240_bib81","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1248\/bpb.b12-00885","article-title":"Mechanism of the Tissue-Specific Action of the Selective Androgen Receptor Modulator S-101479","volume":"36","author":"Furuya","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.forsciint.2024.112240_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114433","article-title":"The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in human athlete","volume":"207","author":"Kintz","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"11\u201312","key":"10.1016\/j.forsciint.2024.112240_bib83","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/dta.2933","article-title":"Elimination profiles of microdosed ostarine mimicking contaminated products ingestion","volume":"12","author":"Walpurgis","year":"2020","journal-title":"Drug Test. Anal."},{"issue":"12","key":"10.1016\/j.forsciint.2024.112240_bib84","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3390\/pharmaceutics13122012","article-title":"Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison","volume":"13","author":"Barnes","year":"2021","journal-title":"Pharmaceutics"},{"issue":"11\u201312","key":"10.1016\/j.forsciint.2024.112240_bib85","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/dta.2951","article-title":"Detection of clostebol in sports: accidental doping?","volume":"vol. 12","author":"Torre","year":"2020","journal-title":"Drug Test. Anal."},{"issue":"21","key":"10.1016\/j.forsciint.2024.112240_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9183","article-title":"Chromatographic-mass spectrometric analysis of the urinary metabolite profile of chlorphenesin observed after dermal application of chlorphenesin-containing sunscreen","volume":"35","author":"Rubio","year":"2021","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.forsciint.2024.112240_bib88","series-title":"Testosterone","first-page":"405","article-title":"Pharmacology of testosterone preparations","author":"Behre","year":"2001"},{"issue":"10","key":"10.1016\/j.forsciint.2024.112240_bib89","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/dta.3355","article-title":"Detectability of oxandrolone, metandienone, clostebol and dehydrochloromethyltestosterone in urine after transdermal application","volume":"14","author":"Gessner","year":"2022","journal-title":"Drug Test. Anal."},{"issue":"5","key":"10.1016\/j.forsciint.2024.112240_bib90","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/dta.2757","article-title":"The case of the EPO-poisoned syringe","volume":"12","author":"Marchand","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2024.112240_bib91","unstructured":"World Anti-Doping Agency, WADA Technical Letter \u2013 TL10- In situ Formation of exogenous compounds in urine samples. 2021."},{"issue":"3","key":"10.1016\/j.forsciint.2024.112240_bib92","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.steroids.2008.11.008","article-title":"Doping in sport: 3. Metabolic conversion of oral norethisterone to urinary 19-norandrosterone","volume":"74","author":"Walker","year":"2009","journal-title":"Steroids"},{"issue":"8","key":"10.1016\/j.forsciint.2024.112240_bib93","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.steroids.2005.01.005","article-title":"Formation of 19-norsteroids by in situ demethylation of endogenous steroids in stored urine samples","volume":"70","author":"Grosse","year":"2005","journal-title":"Steroids"},{"issue":"1\u20133","key":"10.1016\/j.forsciint.2024.112240_bib94","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jsbmb.2009.06.001","article-title":"Excretion of endogenous boldione in human urine: Influence of phytosterol consumption","volume":"117","author":"Verheyden","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.forsciint.2024.112240_bib95","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.steroids.2012.10.020","article-title":"Presence of endogenous prednisolone in human urine","volume":"78","author":"Fidani","year":"2013","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.forsciint.2024.112240_bib96","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/dta.3120","article-title":"Investigations in carbon isotope ratios of seized testosterone and boldenone preparations","volume":"14","author":"Piper","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2024.112240_bib97","first-page":"403","article-title":"Applications of Isotope Ratio Mass Spectrometry in Sports Drug Testing Accounting for Isotope Fractionation in Analysis of Biological Samples","volume":"596","author":"Piper","year":"2017"},{"issue":"1","key":"10.1016\/j.forsciint.2024.112240_bib98","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-4347(96)00032-1","article-title":"Testing for natural and synthetic anabolic agents in human urine","volume":"687","author":"Ayotte","year":"1996","journal-title":"J. Chromatogr. B. Biomed. Sci. Appl."},{"issue":"9","key":"10.1016\/j.forsciint.2024.112240_bib99","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jat\/31.9.543","article-title":"Results of stability studies with doping agents in urine","volume":"31","author":"Van Eenoo","year":"2007","journal-title":"J. Anal. Toxicol."},{"issue":"11\u201312","key":"10.1016\/j.forsciint.2024.112240_bib100","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/dta.202","article-title":"Characterization of microbial contaminants in urine","volume":"2","author":"Ojanper\u00e4","year":"2010","journal-title":"Drug Test. Anal."},{"issue":"2","key":"10.1016\/j.forsciint.2024.112240_bib101","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/abio.2000.4918","article-title":"Changes in androgenic steroid profile due to urine contamination by microorganisms: a prospective study in the context of doping control","volume":"289","author":"De La Torre","year":"2001","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.forsciint.2024.112240_bib103","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ab.2009.02.013","article-title":"Stabilization of human urine doping control samples: II. Microbial degradation of steroids","volume":"388","author":"Tsivou","year":"2009","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.forsciint.2024.112240_bib104","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ab.2009.02.016","article-title":"Stabilization of human urine doping control samples","volume":"388","author":"Tsivou","year":"2009","journal-title":"Anal. Biochem."},{"issue":"5","key":"10.1016\/j.forsciint.2024.112240_bib105","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/dta.2048","article-title":"Doping control container for urine stabilization: a pilot study","volume":"9","author":"Tsivou","year":"2017","journal-title":"Drug Test. Anal."},{"issue":"1\u20133","key":"10.1016\/j.forsciint.2024.112240_bib106","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.forsciint.2011.07.054","article-title":"Fluorescence flow cytometer to determine urine particle reference intervals in doping control samples","volume":"213","author":"Robinson","year":"2011","journal-title":"Forensic Sci. Int."},{"issue":"3","key":"10.1016\/j.forsciint.2024.112240_bib107","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/dta.3011","article-title":"Do dried blood spots have the potential to support result management processes in routine sports drug testing?\u2014Part 2: Proactive sampling for follow-up investigations concerning atypical or adverse analytical findings","volume":"13","author":"Thevis","year":"2021","journal-title":"Drug Test. Anal."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073824003220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073824003220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T12:12:56Z","timestamp":1733400776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073824003220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":99,"alternative-id":["S0379073824003220"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2024.112240","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unravelling the threat of contamination in elite sports: Exploring diverse sources impacting adverse analytical findings and the risk of inadvertent exposure to prohibited substances","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2024.112240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112240"}}